Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 100. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_403	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	40% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_405	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	39% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_407	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	42% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_409	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	40% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_411	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	38% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_413	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	38% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_414	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	35% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_415	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	35% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_416	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	24% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_417	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_418	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_419	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	21% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_420	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_421	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_422	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	12% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_423	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	16% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_424	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	8% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_425	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	12% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_427	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	50% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_429	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	50% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_431	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	51% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_433	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	40% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_435	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	38% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_437	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	40% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_438	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	88% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_439	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	46% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_440	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	62% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_441	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_442	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	26% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_443	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	22% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_444	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	24% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_445	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_446	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_447	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_448	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_449	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	16% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_450	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	90% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_451	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	58% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_452	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	74% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_453	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	22% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_454	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	28% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_455	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_456	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_457	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_458	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_459	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	14% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_460	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	14% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_461	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	14% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_462	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	56% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_463	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	58% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_464	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	24% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_465	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_466	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_467	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_468	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_469	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_470	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_471	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	16% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_472	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	14% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_473	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	12% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_474	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	30% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_475	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	38% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_476	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	22% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_477	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_478	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_479	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_480	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_481	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_482	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_483	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	16% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_484	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	14% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_485	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	14% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_4706	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.001 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4707	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.01 MOI	98% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4708	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.1 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4709	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	1 MOI	75% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4710	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	40% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4711	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.001 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4712	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.01 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4713	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.1 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4714	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	1 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4715	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	50% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4716	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.001 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4717	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.01 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4718	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.1 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4719	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	1 MOI	75% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4720	Myxoma virus	wild type	DNA	Poxviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	50% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4721	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.001 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4722	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.01 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4723	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.1 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4724	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	1 MOI	50% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4725	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	25% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4726	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.001 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4727	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.01 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4728	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.1 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4729	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	1 MOI	75% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4730	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	65% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4731	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.001 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4732	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.01 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4733	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.1 MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	27119108

previous12 3 4 next